New drugs and clinical trial design in advanced sarcoma: have we made any progress?

Author： Constantinidou Anastasia   Miah Aisha   Pollack Seth   Jones Robin L  

Publisher： Future Medicine

ISSN： 1479-6694

Source： Future Oncology, Vol.9, Iss.10, 2013-10, pp. : 1409-1411

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Chemotherapy for advanced and recurrent cervical carcinoma in the new era of upfront chemotherapy and radiation: Have we arrived?

By Monk Bradley  

The Women's Oncology Review, Vol. 5, Iss. 2, 2005-06 ,pp. : 77-80

Informa Healthcare

Access to resources Recommend Favorite

Results of a phase II trial with second-line cystemustine at 60mg/m 2 in advanced soft tissue sarcoma: A trial of the EORTC early clinical studies group

By Cure H.   Krakowski I.   Adenis A.   Tubiana N.   Kerbrat P.   Roche H.   Chevallier   Lentz M.A.   Fumoleau P.   Chollet P.  

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 422-423

Elsevier

Access to resources Recommend Favorite

High-risk soft tissue sarcoma: Clinical trial and hyperthermia combined chemotherapy

By Issels Rolf D.  

International Journal of Hyperthermia, Vol. 22, Iss. 3, 2006-05 ,pp. : 235-239

Informa Healthcare

Access to resources Recommend Favorite

Hepatitis B—Vaccines and Two Drugs Are All We Have

By  

The Genesis Report - Rx, Vol. 10, Iss. 2, 2001-02 ,pp. : 26-32

Adis International

Access to resources Recommend Favorite

Management of advanced prostate cancer –– new drugs

By Ulléén Anders   Shah Carl-Henrik   Kirkali Ziya  

Acta Oncologica, Vol. 50, Iss. 1, 2011-06 ,pp. : 137-140

Informa Healthcare

Access to resources Recommend Favorite